7-99385766-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_005720.4(ARPC1B):āc.52A>Cā(p.Lys18Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,610,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 31)
Exomes š: 0.000012 ( 0 hom. )
Consequence
ARPC1B
NM_005720.4 missense
NM_005720.4 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.64
Genes affected
ARPC1B (HGNC:704): (actin related protein 2/3 complex subunit 1B) This gene encodes one of seven subunits of the human Arp2/3 protein complex. This subunit is a member of the SOP2 family of proteins and is most similar to the protein encoded by gene ARPC1A. The similarity between these two proteins suggests that they both may function as p41 subunit of the human Arp2/3 complex that has been implicated in the control of actin polymerization in cells. It is possible that the p41 subunit is involved in assembling and maintaining the structure of the Arp2/3 complex. Multiple versions of the p41 subunit may adapt the functions of the complex to different cell types or developmental stages. This protein also has a role in centrosomal homeostasis by being an activator and substrate of the Aurora A kinase. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3742745).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000123 (18/1458032) while in subpopulation MID AF= 0.000521 (3/5760). AF 95% confidence interval is 0.000141. There are 0 homozygotes in gnomad4_exome. There are 8 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARPC1B | NM_005720.4 | c.52A>C | p.Lys18Gln | missense_variant | 2/10 | ENST00000646101.2 | NP_005711.1 | |
ARPC1B | XM_024446628.2 | c.52A>C | p.Lys18Gln | missense_variant | 2/10 | XP_024302396.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPC1B | ENST00000646101.2 | c.52A>C | p.Lys18Gln | missense_variant | 2/10 | NM_005720.4 | ENSP00000496599 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152150Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
152150
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 242056Hom.: 0 AF XY: 0.0000229 AC XY: 3AN XY: 131076
GnomAD3 exomes
AF:
AC:
4
AN:
242056
Hom.:
AF XY:
AC XY:
3
AN XY:
131076
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1458032Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 724984
GnomAD4 exome
AF:
AC:
18
AN:
1458032
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
724984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152150Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74314
GnomAD4 genome
AF:
AC:
3
AN:
152150
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.52A>C (p.K18Q) alteration is located in exon 2 (coding exon 1) of the ARPC1B gene. This alteration results from a A to C substitution at nucleotide position 52, causing the lysine (K) at amino acid position 18 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2022 | This sequence change replaces lysine, which is basic and polar, with glutamine, which is neutral and polar, at codon 18 of the ARPC1B protein (p.Lys18Gln). This variant is present in population databases (rs755884757, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ARPC1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1416166). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARPC1B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;T;.;T;.;T;T;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.;.;.;T;T;T;.;.;.;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;M;M;M;.;.;.;M;M;M;M;M
MutationTaster
Benign
N;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.;N;N;N;D;N;N;N;N;N;.
REVEL
Benign
Sift
Benign
.;T;T;.;T;T;T;.;T;T;T;T;T;.
Sift4G
Benign
.;T;T;.;T;T;T;D;T;T;T;T;T;.
Polyphen
0.21
.;.;.;B;B;B;.;.;.;B;B;B;B;B
Vest4
0.31
MutPred
0.48
.;Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);Loss of ubiquitination at K18 (P = 0.0155);
MVP
0.68
MPC
0.45
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at